For more than two decades, my laboratory has been working on developing herpesvirus vaccine vector-based technology to address a range of diseases. We are utilizing this technology to investigate fundamental biological questions, as well as to combat immediate issues like SARS-CoV-2, Ebola and Lassa viruses, other emerging infectious diseases and cancer. In response to the COVID-19 pandemic, my laboratory was also involved in identifying drugs and developing vaccines for SARS-CoV-2. Collaboration is crucial for effective science, and I view my lab as just one member of an international network of interactive researchers. With the ability to genetically engineer herpesvirus vaccines using cutting-edge recombination technology such as bacterial artificial chromosome (BAC) and CRISPR, we are limited only by our imaginations and the realities of Nature.
"For a successful technology, reality must take precedence over public relations, for Nature cannot be fooled" – "You can't pitch Nature."
Richard P. Feynman. "What do you care what other people think?"
